Mycoplasma urealyticum has a comparable incidence in men and women based on the probability of incidence, and there is no order of priority. Under normal circumstances, the body is not infected by these pathogens, but when the body’s resistance decreases, the risk of infection increases. Mycoplasma urealyticum is often found in the urethra and genital tract, and sexual transmission is the main means of transmission. Therefore, if there is sexual confusion, multiple sexual partners, or an unclean sex life, both men and women can become infected with Mycoplasma urealyticum. In addition, Mycoplasma urealyticum can also be transmitted through indirect contact, i.e. if you touch the clothes and bath towels used by the infected person, you may also become infected. Mycoplasma urealyticum infection can cause prostatitis, pyelonephritis, urethritis, and other diseases. In addition, Mycoplasma urealyticum can also infect the fetus via the placenta, causing adverse consequences such as premature birth and miscarriage. The first choice is azithromycin, which is used early, in sufficient quantity and regularly. If resistance to this drug occurs, other antibiotics can be replaced according to the doctor’s recommendation. Patients need to go to the hospital at intervals of 1 week for a review to clarify whether the secretions are negative, forbid sexual intercourse for 1-2 weeks, and pay attention to separate washing of contaminated clothing, diligent change and timely disinfection. At the same time, ensure sufficient sleep, a comprehensive diet and avoid stimulating food.